How to Buy Insmed Stock
Insmed Inc
Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases.
Insmed stock last closed at $27.96, up 1.41% from the previous day, and has increased 50.08% in one year. It has overperformed other stocks in the Biotechnology industry by 0.75 percentage points. Insmed stock is currently +74.31% from its 52-week low of $16.04, and -1.27% from its 52-week high of $28.32.
As of Dec 8, 2023, there are 143.06M shares of INSM outstanding. The market cap of INSM is $4.00B. In the past 24 hours, 1.88M INSM shares were traded.
How to Buy Insmed Stock
Wondering how to invest in Insmed stock? Here's how.
- Figure out where to buy Insmed stock: You need to pick a stock brokerage, but don't worry - we've researched dozens of stock brokerages and apps to help you choose where to buy Insmed stock.
- Sign up for your brokerage account: Sign up for 0% commission trading with the highest-rated brokerage we've identified.
- Deposit funds into your brokerage account: Choose your method of payment and add your information.
- Analyze Insmed stock: The Insmed ticker symbol is INSM. Is Insmed stock a good investment? Should you buy shares of INSM? How do INSM's underlying business fundamentals look? Do top analysts think Insmed is a good buy? Why has INSM's stock price moved recently? (Hint: Our stock market analysis website can help you understand if INSM is a good stock to buy).
- Place your INSM buy order: Decide if you will purchase INSM shares at the current market price or use a limit order to purchase INSM shares at a given price.
- Get updates on your investment in INSM: Create a watchlist to key updates about your investment in Insmed stock.
Step 1: Figure out where to buy Insmed stock
You will need a brokerage account to access the NASDAQ market and buy INSM stock.
Our favorite brokerage: eToro
Based on our experience, eToro is the best brokerage. Here's why:
- You can invest in stocks with 0% commissions: Invest without paying trading commissions.
- Buy fractional shares: Even if you don't have the money to buy a full share, you can still purchase the stock.
- Access to world markets: From Technology to Real Estate, New York to Hong Kong — you can fill your portfolio with stocks from the globe's leading stock exchanges.
- Social investing: eToro has a community of more than 20 million users globally. Talk to, learn from, and copy the crypto trades of other investors.
- Security: eToro is a regulated and licensed brokerage platform.
- Buy other financial assets: Such as ETFs and cryptocurrencies.
Get $10 towards your purchase of stock by signing up for an account with eToro today.
Open eToro AccountStep 2: Sign up for your brokerage account
Now that you've selected the best brokerage, it's time to fill out some personal details so you can buy INSM stock today.
How to Set Up a New Brokerage Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Enter your personal info to open a new trading account.
- Send your data by pressing the "Create Account" button. Get started with eToro today
Step 3: Deposit funds into your brokerage account
Now that you have filled out your info on the best stock broker app, your next step is to transfer the money for your investment:
Watch the video below for more details transferring funds into your brokerage account.
Step 4: Analyze Insmed stock
Once you have identified the best place to buy Insmed stock, it's very important to evaluate their stock prior to buying, so you actually comprehend the risk as well as the upside.
Insmed shares at a glance
INSM Due Diligence Checks
WallStreetZen was created to help average investors perform better fundamental analysis.
You can view all of the due diligence checks on INSM's stock page.
Is INSM stock undervalued or overvalued?
Analysts use a variety of different financial metrics, analyses, models, and charts to gauge INSM's fair value.
You can access additional valuation research on INSM's stock here.
Is INSM a healthy company?
Passed Financial Due Diligence Checks:
- INSM has cash burn of 524403000. It has enough cash and short-term investments to cover this for at least one year.
- There are more short-term assets than short-term liabilities on the INSM balance sheet.
Failed Financial Due Diligence Checks:
- INSM profit margin has gone down from -179.4% to -257.7% in the past year.
- There are more long-term liabilities than short-term assets on the INSM balance sheet.
- Total INSM debt is still negative.
- INSM debt to equity ratio of -5.58 is negative.
- INSM has $785.95M in cash and short term investments. This is not enough to cover its annual cash burn of $524.40M.
Do analysts think it's a good time to buy Insmed stock
Out of 7 sell side analysts who track INSM, the consensus analyst rating on Insmed is a Strong Buy
It's important to note that analyst ratings are not stock recommendations, nor are they investment advice.
Latest INSM Analyst Recommendations
Vamil Divan, a top 6% analyst from Guggenheim reiterates INSM with a strong buy rating and raises their INSM price target from $50.00 to $52.00, on Sep 5, 2023.
Guggenheim's Vamil Divan raised their price target on Insmed (NASDAQ: INSM) by 4% from $50 to $52 on 2023/09/05. The analyst reiterated their Strong Buy rating on the stock.
Following the favorable results of the "Phase 3 ARISE study of ARIKAYCE* in patients with newly diagnosed or recurrent nontuberculous mycobacterial (NTM)** lung infection caused by Mycobacterium avium complex (MAC)** who had not started antibiotics," Divan increased their price target.
Although Guggenheim anticipated an optimistic outcome, actual results are even more polished and compelling, the analyst noted.
Footnotes
* From here: ARIKAYCE is a novel, inhaled, once-daily formulation of amikacin, an established antibiotic that was historically administered intravenously and associated with severe toxicity to hearing, balance, and kidney function.
** From here: Nontuberculous mycobacteria (NTM) are mycobacteria which do not cause tuberculosis or leprosy (also known as Hansen's disease).
*** From here: Mycobacterium avium complex (MAC) lung disease is a rare and serious disorder that can significantly increase morbidity and mortality. Patients with MAC lung disease can experience a range of symptoms that often worsen over time, including chronic cough, dyspnea, fatigue, fever, weight loss, and chest pain.
Matthew Harrison, a bottom 4% analyst from Morgan Stanley reiterates INSM with a strong buy rating and maintains their INSM price target from $41.00 to $41.00, on Aug 4, 2023.
You can dig deeper into what analysts are saying on the Insmed stock forecast page.
INSM Momentum
INSM Growth Numbers
Last year, INSM revenue was $280.82M. In the last four year, INSM's revenue has grown by 29.26% per year. This was slower than the Biotechnology industry average of 37.17%.
Dig into INSM's earnings and revenue performance here.
Who is buying/selling INSM?
In the last 12 months, executives and large shareholders at INSM have bought more shares than they have sold.
William Lewis, Chair and CEO of INSM, was the latest INSM insider to sell. They sold $33,155.76 worth of INSM shares on Oct 27, 2023.
Get more info about who owns INSM stock here.
Does INSM provide a stable income stream?
No, Insmed doesn't provide an income stream by paying out dividends.
INSM Social Trading Data
One of the primary reasons eToro is our top-rated brokerage is because of its social trading community.
Click below to learn what other traders have to say.
Step 5: Place your INSM buy order
There are two primary types of orders:
- Market order: A market order is an order to buy or sell a stock at the best price on the market.
Market orders are mostly fine for most investors. - Limit order: A limit order enables you to buy or sell a security at a specific price (or better).
If you want to make sure you're buying or selling at an exact price limit, place a limit order.
Hit the Open button and eToro will execute your order.
If you want more info about buying stocks on eToro, watch the how to video below:
Step 6: Get updates on your investment in INSM
Now that you own some shares in INSM, you'll want to keep up with your new investment.
Start a watchlist to get notified of important updates regarding your INSM stock.
INSM Feed
How to Buy Stock in Insmed
To summarize, here are the 6 steps you need to take to buy Insmed stock right now:
- Figure out where to buy Insmed stock
- Sign up for your brokerage account
- Deposit funds into your brokerage account
- Analyze Insmed stock
- Place your INSM buy order
- Get updates on your investment in INSM
If you are looking for a brokerage account, eToro is our recommended option.
Get Started with eToro TodayIf you would like to keep tabs on your new investment in Insmed, get started below.
More Articles You May Find Useful
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.